VANGUARD GROUP INC 13D/13G Filings for Cara Therapeutics, Inc. (CARA)

VANGUARD GROUP INC 13D and 13G filings for Cara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-13
5:01 pm
Sale		2023-12-2913GCara Therapeutics, Inc.
CARA		VANGUARD GROUP INC219,256
4.830%		-39,221decrease
(-15.17%)		Filing
2023-02-09
11:12 am
Purchase		2022-12-3013GCara Therapeutics, Inc.
CARA		VANGUARD GROUP INC258,477
5.770%		5,747increase
(+2.27%)		Filing
2022-02-09
3:33 pm
Purchase		2021-12-3113GCara Therapeutics, Inc.
CARA		VANGUARD GROUP INC252,730
5.670%		252,730increase
(New Position)		Filing